סוכרת מסוג 2
הערות שוליים

1 2 3  GBD 2015 Disease and Injury Incidence and Prevalence Collaborators, Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet (London, England) 388, 10 08, 2016, עמ' 1545–1602 doi: 10.1016/S0140-6736(16)31678-6
1 2 3 4 5 6 7 8 9 10  Cynthia M. Ripsin, Helen Kang, Randall J. Urban, Management of blood glucose in type 2 diabetes mellitus, American Family Physician 79, 2009-01-01, עמ' 29–36
1 2  National Institute of Diabetes and Digestive and Kidney Diseases, Causes of Diabetes, June 2014
1 2 3 4 5  National Institute of Diabetes and Digestive and Kidney Diseases, Diagnosis of Diabetes and Prediabetes, June 2014
1 2 3  Nisa M. Maruthur, Eva Tseng, Susan Hutfless, Lisa M. Wilson, Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis, Annals of Internal Medicine 164, 2016-06-07, עמ' 740–751 doi: 10.7326/M15-2650
1 2 3 4 5 6 7  World Health Organization, Diabetes Fact Sheet number 312
↑  Suleyman Cetinkunar, Hasan Erdem, Recep Aktimur, Selim Sozen, Effect of bariatric surgery on humoral control of metabolic derangements in obese patients with type 2 diabetes mellitus: How it works, World Journal of Clinical Cases 3, 2015-06-16, עמ' 504–509 doi: 10.12998/wjcc.v3.i6.504
↑  Andrew J. Krentz, Clifford J. Bailey, Oral antidiabetic agents: current role in type 2 diabetes mellitus, Drugs 65, 2005, עמ' 385–411 doi: 10.2165/00003495-200565030-00005
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  מכבי שירותי בריאות, אבחון של סוכרת סוג 2, ‏12.10.2009
1 2 3 4 5 6 7 8 9 10 11 12 13  Melmed, Shlomo; Polonsky, Kenneth S.; Larsen, P. Reed; Kronenberg, Henry M. (eds.), Williams textbook of endocrinology., 12th ed., Philadelphia: Elsevier/Saunders, 2011, עמ' 1371–1435
1 2  King H, Aubert RE, Herman W, Global burden of diabetes 1995-2025, prevalence, numerical estimates and projections, Diabetes Care 1998;21:1414-1431
↑  A. Saenz, I. Fernandez-Esteban, A. Mataix, M. Ausejo, Metformin monotherapy for type 2 diabetes mellitus, The Cochrane Database of Systematic Reviews, 2005-07-20, עמ' CD002966 doi: 10.1002/14651858.CD002966.pub3
↑  Zimmet P, Alberti KG, Shaw J, Global and societal implications of the diabetes epidemic, Nature, 2001;414:782-787
↑  Public health nursing : practicing population-based care, 2nd ed, Burlington, Mass.: Jones & Bartlett Learning, 2013
1 2 3 4 5 6  ד"ר דנה פלורנטין, ד"ר אברהם ישי, ד"ר ילנה צ'רטוק שחם, סוכרת - המדריך המלא, באתר קופת חולים כללית
↑  Giuseppina Imperatore, James P. Boyle, Theodore J. Thompson, Doug Case, Projections of Type 1 and Type 2 Diabetes Burden in the U.S. Population Aged, Diabetes Care 35, 2012-12, עמ' 2515–2520 doi: 10.2337/dc12-0669
↑  Hala Tfayli, Silva Arslanian, Pathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon, Arquivos Brasileiros De Endocrinologia E Metabologia 53, 2009-3, עמ' 165–174
1 2 3 4 5  Zajac, Jacek; Shrestha, Anil; Patel, Parini; Poretsky, Leonid, "The Main Events in the History of Diabetes Mellitus", Principles of Diabetes Mellitus, 2nd ed, New York: Springer Verlag, 2010, עמ' 3-16
↑  Konstantinos Laios,1 Marianna Karamanou,1 Zenia Saridaki,2 George Androutsos1, Aretaeus of Cappadocia and the first description of diabetes, HORMONES, 2012, עמ' 11(1):109-113
↑  O. Minkowski, J. v Mering, Diabetes mellitus nach Pankreasexstirpation, Archiv für experimentelle Pathologie und Pharmakologie 26, 1890-01-01, עמ' 371–387 doi: 10.1007/BF01831214
1 2 3  Bliss, Michael, 1941-2017., The discovery of insulin, Chicago: University of Chicago Press, 1982
↑  University of Toronto Libraries, "Nobel Prize medal inscribed to F. G. Banting", ‏Royal Karolinska Institute (1923)
1 2  P. Valensi, J. Pariès, J. R. Attali, French Group for Research and Study of Diabetic Neuropathy, Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications--the French multicenter study, Metabolism: Clinical and Experimental 52, 2003-7, עמ' 815–820
↑  Vesa Jokinen, Olavi Ukkola, K. E. Juhani Airaksinen, Juhani M. Koistinen, Temporal changes in cardiovascular autonomic regulation in type II diabetic patients: association with coronary risk variables and progression of coronary artery disease, Annals of Medicine 35, 2003, עמ' 216–223
↑  נתוני מחלות כרוניות, משרד הבריאות
↑  המרכז הלאומי לבקרת מחלות, משרד הבריאות, דו"ח רישום סוכרת לשנים 2012–2013
↑  Masaaki Kataoka, Chikako Ito, Hideo Sasaki, Kiminori Yamane, Low heart rate variability is a risk factor for sudden cardiac death in type 2 diabetes, Diabetes Research and Clinical Practice 64, 2004-4, עמ' 51–58 doi: 10.1016/j.diabres.2003.10.009
↑  William Whang, J. Thomas Bigger, Comparison of the prognostic value of RR-interval variability after acute myocardial infarction in patients with versus those without diabetes mellitus, The American Journal of Cardiology 92, 2003-08-01, עמ' 247–251
↑  נתונים על מחלת הסוכרת בישראל, מרכז המחקר והמידע של הכנסת, 18 בינואר 2023
↑  הלשכה המרכזית לסטטיסטיקה, סקר בריאות
1 2 3  Ofra Kalter-Leibovici, Arnona Ziv, Maslama Baidousi, Bernice Oberman, Adult Arabs have higher risk for diabetes mellitus than Jews in Israel, PLOS ONE 12, 2017-05-08, עמ' e0176661 doi: 10.1371/journal.pone.0176661
↑  N. D, Challenges facing minority women in achieving good health: voices of Arab women in Israel, Women Health, 2008, עמ' 48:145-166 doi: 10.1080/03630240802313530
↑  המרכז הלאומי לבקרת מחלות, משרד הבריאות, סקר בריאות לאומי בישראל 3 - INHIS 2015-2013 ממצאים נבחרים, ‏2017;(פרסום 374)
↑  שיעורי תמותה לפי סיבות מוות, באתר הלשכה המרכזית לסטטיסטיקה, תת נושא: סוכרת, טווח זמנים 1998-2019, ‏2019
↑  Nihaya Daoud, Challenges facing minority women in achieving good health: voices of Arab women in Israel, Women & Health 48, 2008, עמ' 145–166 doi: 10.1080/03630240802313530
1 2  Anat Jaffe, Shmuel Giveon, Liat Wulffhart, Bernice Oberman, Diabetes among Ethiopian Immigrants to Israel: Exploring the Effects of Migration and Ethnicity on Diabetes Risk, PloS One 11, 2016, עמ' e0157354 doi: 10.1371/journal.pone.0157354
↑  Rachel Wilf-Miron, Ronit Peled, Einat Yaari, Orna Shem-Tov, Disparities in diabetes care: role of the patient's socio-demographic characteristics, BMC public health 10, 2010-11-25, עמ' 729 doi: 10.1186/1471-2458-10-729
1 2 3 4 5 6 7 8 9 10 11  Gardner, David G.; Shoback, Dolores, eds., "Chapter 17: Pancreatic hormones & diabetes mellitus", Greenspan's basic & clinical endocrinology, 9th ed, New York: McGraw-Hill Medical, 2011
↑  N. Abate, M. Chandalia, Ethnicity and type 2 diabetes: focus on Asian Indians, Journal of Diabetes and Its Complications 15, 2001-11, עמ' 320–327
1 2 3 4 5 6  Sandeep Vijan, In the clinic. Type 2 diabetes, Annals of Internal Medicine 152, 2010-03-02, עמ' ITC31–15; quiz ITC316 doi: 10.7326/0003-4819-152-5-201003020-01003
↑  L. Carulli, S. Rondinella, S. Lombardini, I. Canedi, Review article: diabetes, genetics and ethnicity, Alimentary Pharmacology & Therapeutics 22 Suppl 2, 2005-11, עמ' 16–19 doi: 10.1111/j.1365-2036.2005.02588.x
1 2  Simon Smyth, Andrew Heron, Diabetes and obesity: the twin epidemics, Nature Medicine 12, 2006-1, עמ' 75–80 doi: 10.1038/nm0106-75
↑  International Diabetes Federation, [file:///:/Users/malfo/Downloads/IDF_Atlas_8e_Final_EN.pdf IDF Diabetes Atlas, Eighth edition], ‏2017 (ארכיון)
↑  Diabetes mellitus : a guide to patient care., Philadelphia: Lippincott Williams & Wilkins, 2007
↑  ד"ר ברכה דגן, סוכרת מסוג 2
1 2  Ulf Risérus, Walter C. Willett, Frank B. Hu, Dietary fats and prevention of type 2 diabetes, Progress in Lipid Research 48, 2009-1, עמ' 44–51 doi: 10.1016/j.plipres.2008.10.002
↑  Carol Touma, Silvana Pannain, Does lack of sleep cause diabetes?, Cleveland Clinic Journal of Medicine 78, 2011-8, עמ' 549–558 doi: 10.3949/ccjm.78a.10165
↑  Asnawi Abdullah, Anna Peeters, Maximilian de Courten, Johannes Stoelwinder, The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies, Diabetes Research and Clinical Practice 89, 2010-9, עמ' 309–319 doi: 10.1016/j.diabres.2010.04.012
↑  An Pan, Yeli Wang, Mohammad Talaei, Frank B. Hu, Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis, The Lancet. Diabetes & Endocrinology 3, 2015-12, עמ' 958–967 doi: 10.1016/S2213-8587(15)00316-2
↑  Vasanti S. Malik, Barry M. Popkin, George A. Bray, Jean-Pierre Després, Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis, Diabetes Care 33, 2010-11, עמ' 2477–2483 doi: 10.2337/dc10-1079
1 2  Vasanti S. Malik, Barry M. Popkin, George A. Bray, Jean-Pierre Després, Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk, Circulation 121, 2010-03-23, עמ' 1356–1364 doi: 10.1161/CIRCULATIONAHA.109.876185
↑  Emily A. Hu, An Pan, Vasanti Malik, Qi Sun, White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review, BMJ (Clinical research ed.) 344, 2012-03-15, עמ' e1454 doi: 10.1136/bmj.e1454
↑  I.-Min Lee, Eric J. Shiroma, Felipe Lobelo, Pekka Puska, Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy, Lancet (London, England) 380, 2012-07-21, עמ' 219–229 doi: 10.1016/S0140-6736(12)61031-9
↑  L. Lind, P. M. Lind, Can persistent organic pollutants and plastic-associated chemicals cause cardiovascular disease?, Journal of Internal Medicine 271, 2012-6, עמ' 537–553 doi: 10.1111/j.1365-2796.2012.02536.x
1 2  Christian Herder, Michael Roden, Genetics of type 2 diabetes: pathophysiologic and clinical relevance, European Journal of Clinical Investigation 41, 2011-6, עמ' 679–692 doi: 10.1111/j.1365-2362.2010.02454.x
↑  National Diabetes Information Clearinghouse (NDIC), "Monogenic Forms of Diabetes: Neonatal Diabetes Mellitus and Maturity-onset Diabetes of the Young", National Institute of Diabetes and Digestive and Kidney Diseases, NIH., March 2007
1 2  Type 2 diabetes mellitus : an evidence-based approach to practical management, Totowa, NJ: Humana Press, 2008, עמ' 462
↑  Hassane Izzedine, Vincent Launay-Vacher, Camille Deybach, Edward Bourry, Drug-induced diabetes mellitus, Expert Opinion on Drug Safety 4, 2005-11, עמ' 1097–1109 doi: 10.1517/14740338.4.6.1097
↑  Uchechukwu K. Sampson, Macrae F. Linton, Sergio Fazio, Are statins diabetogenic?, Current Opinion in Cardiology 26, 2011-7, עמ' 342–347 doi: 10.1097/HCO.0b013e3283470359
↑  Joanne B. Farrell, Anjali Deshmukh, Ali A. Baghaie, Low testosterone and the association with type 2 diabetes, The Diabetes Educator 34, 2008-9, עמ' 799–806 doi: 10.1177/0145721708323100
↑  Farid Saad, Louis Gooren, The role of testosterone in the metabolic syndrome: a review, The Journal of Steroid Biochemistry and Molecular Biology 114, 2009-3, עמ' 40–43
↑  Sandeep Vijan, In the clinic. Type 2 diabetes, Annals of Internal Medicine 152, 2010-03-02, עמ' ITC31–15; quiz ITC316 doi: 10.7326/0003-4819-152-5-201003020-01003
1 2 3  Gardner, David G.; Shoback, Dolores, eds, "Chapter 17: Pancreatic hormones & diabetes mellitus". Greenspan's basic & clinical endocrinology (9th ed.), New York: McGraw-Hill Medical, 2011
↑  Diabetes symptoms: When diabetes symptoms are a concern, באתר מאיו קליניק, ‏3 ביוני 2021 (באנגלית)
MayoClinic, Type 2 diabetes symptoms
יולי שפיר, הרבה בשירותים? 10 סימנים מתריעים לסוכרת, באתר ynet, 31 ביולי 2012
↑  Polyuria – Frequent Urination, באתר Diabetes.co.uk, ‏15 בינואר 2019 (באנגלית)
↑  Blurred Vision, באתר Diabetes.co.uk, ‏15 בינואר 2019 (באנגלית)
1 2  בדיקת מעבדה - HEMOGLOBIN A1C, באתר קופת חולים כללית
↑  National Institute of Diabetes and Digestive and Kidney Diseases, The A1C Test & Diabetes, ‏April 2018
↑  Andrea D. Smith, Alessio Crippa, James Woodcock, Søren Brage, Physical activity and incident type 2 diabetes mellitus: a systematic review and dose-response meta-analysis of prospective cohort studies, Diabetologia 59, 12 2016, עמ' 2527–2545 doi: 10.1007/s00125-016-4079-0
↑  Diana Thomas, Elizabeth J Elliott, Geraldine A Naughton, Exercise for type 2 diabetes mellitus, Cochrane Database of Systematic Reviews, 2006-07-19 doi: 10.1002/14651858.cd002968.pub2
1 2  Silvano Zanuso, A. Jimenez, G. Pugliese, G. Corigliano, Exercise for the management of type 2 diabetes: a review of the evidence, Acta Diabetologica 47, 2010-3, עמ' 15–22 doi: 10.1007/s00592-009-0126-3
1 2  Nichola Davis, Bernice Forbes, Judith Wylie‐Rosett, Nutritional Strategies in Type 2 Diabetes Mellitus, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 76, 2009, עמ' 257–268 doi: 10.1002/msj.20118
↑  Richard D. Feinman, Wendy K. Pogozelski, Arne Astrup, Richard K. Bernstein, Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base, Nutrition (Burbank, Los Angeles County, Calif.) 31, 2015-1, עמ' 1–13 doi: 10.1016/j.nut.2014.06.011
↑  Diana Thomas, Elizabeth J. Elliott, Low glycaemic index, or low glycaemic load, diets for diabetes mellitus, The Cochrane Database of Systematic Reviews, 2009-01-21, עמ' CD006296 doi: 10.1002/14651858.CD006296.pub2
↑  Peter Clifton, Assessing the evidence for weight loss strategies in people with and without type 2 diabetes, World Journal of Diabetes 8, 2017-10-15, עמ' 440–454 doi: 10.4239/wjd.v8.i10.440
↑  Marian Glick-Bauer, Ming-Chin Yeh, The health advantage of a vegan diet: exploring the gut microbiota connection, Nutrients 6, 2014-10-31, עמ' 4822–4838 doi: 10.3390/nu6114822
↑  Matthew J. Leach, Saravana Kumar, Cinnamon for diabetes mellitus, The Cochrane Database of Systematic Reviews, 2012-09-12, עמ' CD007170 doi: 10.1002/14651858.CD007170.pub2
↑  Madeleine Attridge, John Creamer, Michael Ramsden, Rebecca Cannings-John, Culturally appropriate health education for people in ethnic minority groups with type 2 diabetes mellitus, The Cochrane Database of Systematic Reviews, 2014-09-04, עמ' CD006424 doi: 10.1002/14651858.CD006424.pub3
1 2 3 4 5 6 7  ד"ר אסי סיקורל, ד"ר קובי כהן, מדריך התרופות השלם לסוכרת מסוג 2, באתר קופת חולים כללית
↑  Suetonia C. Palmer, Dimitris Mavridis, Antonio Nicolucci, David W. Johnson, Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis, JAMA 316, 2016-07-19, עמ' 313–324 doi: 10.1001/jama.2016.9400
↑  Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaela Diamant, Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes, Diabetologia 58, 2015-3, עמ' 429–442 doi: 10.1007/s00125-014-3460-0
↑  Samantha M. Kimball, Mohsen Mazidi, Hassanali Vatanparast, Naghmeh Mirhosseini, The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis, The Journal of Clinical Endocrinology & Metabolism 102, 2017-09-01, עמ' 3097–3110 doi: 10.1210/jc.2017-01024
↑  Helen M. Colhoun, D. John Betteridge, Paul N. Durrington, Graham A. Hitman, H. Andrew W. Neil, Shona J. Livingstone, Margaret J. Thomason, Michael I. Mackness, Valentine Charlton-Menys, John H. Fuller, CARDS investigators, Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial, Lancet (London, England) 364, 2021-08-20, עמ' 685–696 doi: 10.1016/S0140-6736(04)16895-5 (באנגלית)
↑  Michael Ej Lean, Wilma S. Leslie, Alison C. Barnes, Naomi Brosnahan, George Thom, Louise McCombie, Carl Peters, Sviatlana Zhyzhneuskaya, Ahmad Al-Mrabeh, Kieren G. Hollingsworth, Angela M. Rodrigues, Lucia Rehackova, Ashley J. Adamson, Falko F. Sniehotta, John C. Mathers, Hazel M. Ross, Yvonne McIlvenna, Renae Stefanetti, Michael Trenell, Paul Welsh, Sharon Kean, Ian Ford, Alex McConnachie, Naveed Sattar, Roy Taylor, Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial, Lancet (London, England) 391, 2018-02-10, עמ' 541–551 doi: 10.1016/S0140-6736(17)33102-1 (באנגלית)
↑  Roger T. Anderson, K. M. Venkat Narayan, Patricia Feeney, David Goff, Mohammed K. Ali, Debra L. Simmons, Jo-Ann Sperl-Hillen, Thomas Bigger, Robert Cuddihy, Patrick J. O'Conner, Ajay Sood, Ping Zhang, Mark D. Sullivan, Action to Control Cardiovascular Risk in Diabetes (ACCORD) Investigators, Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial, Diabetes Care 34, 2011-04, עמ' 807–812 doi: 10.2337/dc10-1926 (באנגלית)
↑  ACCORD Study Group, William C. Cushman, Gregory W. Evans, Robert P. Byington, David C. Goff, Richard H. Grimm, Jeffrey A. Cutler, Denise G. Simons-Morton, Jan N. Basile, Marshall A. Corson, Jeffrey L. Probstfield, Lois Katz, Kevin A. Peterson, William T. Friedewald, John B. Buse, J. Thomas Bigger, Hertzel C. Gerstein, Faramarz Ismail-Beigi, Effects of intensive blood-pressure control in type 2 diabetes mellitus, The New England Journal of Medicine 362, 2010-04-29, עמ' 1575–1585 doi: 10.1056/NEJMoa1001286 (באנגלית)
↑  Faramarz Ismail-Beigi, Timothy E. Craven, Patrick J. O'Connor, Diane Karl, Jorge Calles-Escandon, Irene Hramiak, Saul Genuth, William C. Cushman, Hertzel C. Gerstein, Jeffrey L. Probstfield, Lois Katz, Ulrich Schubart, ACCORD Study Group, Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients, Kidney International 81, 2012-03, עמ' 586–594 doi: 10.1038/ki.2011.415 (באנגלית)
↑  Action to Control Cardiovascular Risk in Diabetes Study Group, Hertzel C. Gerstein, Michael E. Miller, Robert P. Byington, David C. Goff, J. Thomas Bigger, John B. Buse, William C. Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H. Grimm, Jeffrey L. Probstfield, Denise G. Simons-Morton, William T. Friedewald, Effects of intensive glucose lowering in type 2 diabetes, The New England Journal of Medicine 358, 2008-06-12, עמ' 2545–2559 doi: 10.1056/NEJMoa0802743 (באנגלית)
↑  ACCORD Study Group, Henry N. Ginsberg, Marshall B. Elam, Laura C. Lovato, John R. Crouse, Lawrence A. Leiter, Peter Linz, William T. Friedewald, John B. Buse, Hertzel C. Gerstein, Jeffrey Probstfield, Richard H. Grimm, Faramarz Ismail-Beigi, J. Thomas Bigger, David C. Goff, William C. Cushman, Denise G. Simons-Morton, Robert P. Byington, Effects of combination lipid therapy in type 2 diabetes mellitus, The New England Journal of Medicine 362, 2010-04-29, עמ' 1563–1574 doi: 10.1056/NEJMoa1001282 (באנגלית)
↑  Sanjay Basu, Sridharan Raghavan, Deborah J. Wexler, Seth A. Berkowitz, Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial, Diabetes Care 41, 2018-03, עמ' 604–612 doi: 10.2337/dc17-2252 (באנגלית)
↑  ACCORD Study Group, Henry N. Ginsberg, Marshall B. Elam, Laura C. Lovato, John R. Crouse, Lawrence A. Leiter, Peter Linz, William T. Friedewald, John B. Buse, Hertzel C. Gerstein, Jeffrey Probstfield, Richard H. Grimm, Faramarz Ismail-Beigi, J. Thomas Bigger, David C. Goff, William C. Cushman, Denise G. Simons-Morton, Robert P. Byington, Effects of combination lipid therapy in type 2 diabetes mellitus, The New England Journal of Medicine 362, 2010-04-29, עמ' 1563–1574 doi: 10.1056/NEJMoa1001282 (באנגלית)
↑  Action to Control Cardiovascular Risk in Diabetes Study Group, Hertzel C. Gerstein, Michael E. Miller, Robert P. Byington, David C. Goff, J. Thomas Bigger, John B. Buse, William C. Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H. Grimm, Jeffrey L. Probstfield, Denise G. Simons-Morton, William T. Friedewald, Effects of intensive glucose lowering in type 2 diabetes, The New England Journal of Medicine 358, 2008-06-12, עמ' 2545–2559 doi: 10.1056/NEJMoa0802743 (באנגלית)
↑  Joel M. Gore, MD, Glucose-Control Arm of ACCORD Trial Halted Early, www.jwatch.org, ‏February 13, 2008 (באנגלית)
↑  J. Picot, J. Jones, J. L. Colquitt, E. Gospodarevskaya, The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation, Health Technology Assessment (Winchester, England) 13, 2009-9, עמ' 1–190, 215–357, iii-iv doi: 10.3310/hta13410
↑  Katherine J. Frachetti, Allison B. Goldfine, Bariatric surgery for diabetes management, Current Opinion in Endocrinology, Diabetes, and Obesity 16, 2009-4, עמ' 119–124 doi: 10.1097/MED.0b013e32832912e7
1 2  Aaron P. Schulman, Federica del Genio, Naina Sinha, Francesco Rubino, "Metabolic" surgery for treatment of type 2 diabetes mellitus, Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 15, 2009-9, עמ' 624–631 doi: 10.4158/EP09170.RAR
↑  Randall A. Colucci, Bariatric surgery in patients with type 2 diabetes: a viable option, Postgraduate Medicine 123, 2011-1, עמ' 24–33 doi: 10.3810/pgm.2011.01.2242
↑  Francesco Rubino, David M. Nathan, Robert H. Eckel, Philip R. Schauer, Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations, Diabetes Care 39, 06 2016, עמ' 861–877 doi: 10.2337/dc16-0236
↑  John B. Dixon, Carel W. le Roux, Francesco Rubino, Paul Zimmet, Bariatric surgery for type 2 diabetes, Lancet (London, England) 379, 2012-06-16, עמ' 2300–2311 doi: 10.1016/S0140-6736(12)60401-2
↑  ניתוח בריאטרי יעיל יותר מטיפול תרופתי בלבד במטופלים עם סוכרת והשמנת יתר, באתר איגוד רופאי בריאות הציבור בישראל, ‏23 בפברואר 2017
↑  סוכרת סוג 2: המסלול להחלמה מלאה באמצעות ניתוח בריאטרי, באתר BEOK, ‏13 בנובמבר 2019
↑  ניתוח בריאטרי או טיפול תרופתי אינטנסיבי בסוכרת סוג 2 והשמנת יתר – מעקב של 5 שנים, באתר אגודה ישראלית לסוכרת, ‏26 בפברואר 2017
↑  Leonardo J. Orozco, Ana Maria Buchleitner, Gabriel Gimenez-Perez, Marta Roqué I Figuls, Exercise or exercise and diet for preventing type 2 diabetes mellitus, The Cochrane Database of Systematic Reviews, 2008-07-16, עמ' CD003054 doi: 10.1002/14651858.CD003054.pub3
↑  C. Raina Elley, Tim Kenealy, Lifestyle interventions reduced the long-term risk of diabetes in adults with impaired glucose tolerance, Evidence-Based Medicine 13, 2008-12, עמ' 173 doi: 10.1136/ebm.13.6.173
↑  Elizabeth Sumamo Schellenberg, Donna M. Dryden, Ben Vandermeer, Christine Ha, Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis, Annals of Internal Medicine 159, 2013-10-15, עמ' 543–551 doi: 10.7326/0003-4819-159-8-201310150-00007
↑  Donal J. O'Gorman, Anna Krook, Exercise and the treatment of diabetes and obesity, The Medical Clinics of North America 95, 2011-9, עמ' 953–969 doi: 10.1016/j.mcna.2011.06.007
↑  Hmwe H. Kyu, Victoria F. Bachman, Lily T. Alexander, John Everett Mumford, Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013, BMJ (Clinical research ed.) 354, 2016-08-09, עמ' i3857 doi: 10.1136/bmj.i3857
↑  Lucie Nield, Carolyn D. Summerbell, Lee Hooper, Vicki Whittaker, Dietary advice for the prevention of type 2 diabetes mellitus in adults, The Cochrane Database of Systematic Reviews, 2008-07-16, עמ' CD005102 doi: 10.1002/14651858.CD005102.pub2
↑  Patrice Carter, Laura J. Gray, Jacqui Troughton, Kamlesh Khunti, Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis, BMJ (Clinical research ed.) 341, 2010-08-18, עמ' c4229 doi: 10.1136/bmj.c4229
↑  P. L. Santaguida, C. Balion, D. Hunt, K. Morrison, Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose, Evidence Report/Technology Assessment (Summary), 2005-8, עמ' 1–11
↑  J. Sonya Haw, Karla I. Galaviz, Audrey N. Straus, Alysse J. Kowalski, Long-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical Trials, JAMA internal medicine 177, 2017-12-01, עמ' 1808–1817 doi: 10.1001/jamainternmed.2017.6040
↑  Jennifer C. Seida, Joanna Mitri, Isabelle N. Colmers, Sumit R. Majumdar, Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis, The Journal of Clinical Endocrinology and Metabolism 99, 2014-10, עמ' 3551–3560 doi: 10.1210/jc.2014-2136
| --- | --- |
ערך מומלץ: 
| --- | --- |
בקרת זהויות :  NLI: 987012431017005171  LCCN: sh85092226  LNB: 000261970 
הבהרה: המידע בוויקיפדיה נועד להעשרה בלבד ואינו מהווה ייעוץ רפואי.
שיעורים אזוריים של מחלת הסוכרת באמצעות נתונים מ-195 מדינות בשנת 2014
מנגנון של ספיגה תקינה של סוכר בדם (משמאל), מנגד למצב של תנגודת האינסולין(אנ') בסוכרת מסוג 2 (מימין)
מחקר ACCORD-BP: תוצאת 'איזון לחץ דם הדוק' מול 'רגיל' לחולי סוכרת למשך 5 שנים (אחוז מהנבדקים לשנה)
גרף תוצאת מחקר ACCORD-LIPID: 'איזון שומני דם הדוק' מול 'רגיל' אצל חולי סוכרת. תוצא משולב הוגדר כאוטם שריר לב לא קטלני, שבץ מוחי לא קטלני או מוות מסיבות קרדיווסקולריות.
גרף תוצאות מחקר ACCORD-GLUCOSE 'איזון סוכרת תרופתי הדוק' מול 'רגיל'. המחקר הופסק לאחר 4 שנים עקב הצטברות אירועי בריאות לא רצויים חמורים בקבוצת הטיפול ההדוק.